Patent US4766072A successfully refreshed from Google Patents.
US4766072A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Vectors for in vitro production of RNA copies of either strand of a cloned DNA sequence
Assignee: Promega Corp
•
Filing: 1985-07-17
•
Granted: 1988-08-23
•
Expires: 2005-07-17
Abstract
Abstract In vitro production of RNA copies of either strand of any cloned DNA sequence may be obtained utilizing a unique cloning vector having two different opposed promoter sequences which are separated by a multiple cloning site. RNA polymerases which recognize only one of the particular promoter sequences in the vector may be applied to obtain transcription which proceeds from the recognized promoter toward the other promoter. Transcription of a desired strand of any DNA sequence is obtained by cleaving a particular restriction site in the multiple cloning site between the two promoter sequences, cloning the desired DNA sequence into the cleaved site, then cleaving another site between the two promoters which is distal to the promoter from which transcription is desired. The RNA polymerase which recognizes the selected promoter may then be applied to the vector to obtain transcription of the selected DNA sequence in vitro. Double stranded RNA may also be formed utilizing the vector by providing multiple vectors cleaved on either side of the DNA segment and thereafter applying the two RNA polymerases to cause transcription of both strands of the selected DNA segment. Specific cloning vectors are novel plasmids designated pGEM-1 and pGEM-2 which are characterized by having the SP6 and T7 late phage promoters facing each other separated by a multiple cloning site.
Inventors
- 👤 Jerome J. Jendrisak
- 👤 Martin K. Lewis
- 👤 Michael J. Fiandt
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-03 06:33
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/70; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/34
Claims Analysis
Total Claims: 23
Claim 1
Independent Claim
263 words
A method of producing RNA copies in vitro of a selected DNA sequence, comprising the steps of: (a) providing a DNA cloning vector comprised of double stranded DNA having two different phage promoter sequences facing each other such that transcription from either phage promoter proceeds in the opposite direction of transcription from and toward the other phage promoter, each phage promoter sequence recognized by a phage encoded RNA polymerase which is specific to that phage promoter and which recognizes no other sequence in the vector, the two phage promoters having located between them a cloning site composed of a sequence of DNA base pairs which includes at least one restriction endonuclease cleavage site which is cleaved by an endonuclease which cleaves no other site on the vector; (b) applying to the vector a restriction enzyme specific to a selected restriction site between the two opposed phage promoters to cleave the vector at said site; (c) inserting the selected DNA sequence into the cleaved site; (d) cloning the vector with the inserted DNA sequence in a suitable host; (e) purifying the vector with the inserted DNA sequence and resuspending said vector in an aqueous solution; (f) applying a restriction enzyme to the vector which recognizes a restriction site between the inserted DNA and one of the opposed phase promoters to cleave the vector at said site; and (g) applying to the cleaved vector the phage encoded RNA. polymerase specific to the phase promoter remaining adjacent to the inserted DNA segment in an RNA generating medium to provide RNA copies of the selected DNA sequence.
Claim 2
Independent Claim
263 words
A method of producing RNA copies in vitro of a selected DNA sequence, comprising the steps of: (a) providing a DNA cloning vector comprised of double stranded DNA having two different phage promoter sequences facing each other such that transcription from either phage promoter proceeds in the opposite direction of transcription from and toward the other phage promoter, each phage promoter sequence recognized by a phage encoded RNA polymerase which is specific to that phage promoter and which recognizes no other sequence in the vector, the two phage promoters having located between them a cloning site composed of a sequence of DNA base pairs which includes at least one restriction endonuclease cleavage site which is cleaved by an endonuclease which cleaves no other site on the vector; (b) applying to the vector a restriction enzyme specific to a selected restriction site between the two opposed phage promoters to cleave the vector at said site; (c) inserting the selected DNA sequence into the cleaved site; (d) cloning the vector with the inserted DNA sequence in a suitable host; (e) purifying the vector with the inserted DNA sequence and resuspending said vector in an aqueous solution; (f) applying a restriction enzyme to the vector which recognizes a restriction site between the inserted DNA and one of the opposed phase promoters to cleave the vector at said site; and (g) applying to the cleaved vector the phage encoded RNA. polymerase specific to the phase promoter remaining adjacent to the inserted DNA segment in an RNA generating medium to provide RNA copies of the selected DNA sequence.
Claim 3
Dependent Claim
169 words
The method of claim 1 wherein the selected DNA sequence is inserted into a plurality of copies of the vector and, after the step of cloning the vector with the inserted DNA sequence and before the step of applying a restriction enzyme, further comprising the step of dividing the aqueous solution containing the vectors carrying the inserted DNA sequence into two groups, in step (f) cleaving one group with a restriction enzyme specific to a site between the inserted DNA sequence and the first one of the two phage promoters and cleaving the second group with a restriction enzyme specific to a site between the inserted DNA sequence and the second of the two phage promoters, and in step (g) applying the two phage encoded RNA polymerases which are specific to the two phase promoter sequences in an RNA generating medium whereby both strands of the inserted DNA sequence will be transcribed and the RNA transcribed from the opposite strands will be available to hybridize to form double-stranded RNA.
Claim 4
Dependent Claim
13 words
The method of claim 1 wherein the vector provided is the plasmid pGEM-1.
Claim 5
Dependent Claim
13 words
The method of claim 1 wherein the vector provided is the plasmid pGEM-2.
Claim 6
Dependent Claim
24 words
The method of claim 1 wherein the two opposed promoter sequences in the vector provided are the SP6 and T7 late phage promoter sequences.
Claim 7
Dependent Claim
127 words
The method of claim 1 wherein the cloning site between the two opposed phage promoters on the vector provided has plural distinct restriction sites selected from the group consisting of sites cleaved by at least one of the following endonucleases; Hind III, PST I, Sal I, ACC I, Hinc II, Xba I, Bam HI, Ava I, Sma I, Sac I and Eco RI, and wherein the restriction enzyme or enzymes applied in step (b) is an endonuclease selected from the group consisting of at least one of Hind III, Pst I, Sal I, Acc I, Hinc II, Xba I, Bam HI, Ava I, Sma I, Sac I, and Eco RI which cleaves its restriction site to leave ends complementary to the ends of the selected DNA sequence.
Claim 8
Dependent Claim
121 words
A DNA cloning vector for use in production in vitro of RNA copies of a cloned DNA sequence comprising: double stranded DNA having two different phage promoter sequences facing each other such that transcription from either phage promoter proceeds toward the other phage promoter and in a direction opposite from the direction of transcription of the other phage promoter, each phage promoter sequence being one that is recognized by a phase encoded RNA polymerase which is specific to that phage promoter and which does not recognize the other phage promoter, the two phage promoters being located closely adjacent opposite sides of a cloning site composed of a sequence of DNA base pairs which includes at least one restriction enzyme cleavage site.
Claim 9
Dependent Claim
121 words
A DNA cloning vector for use in production in vitro of RNA copies of a cloned DNA sequence comprising: double stranded DNA having two different phage promoter sequences facing each other such that transcription from either phage promoter proceeds toward the other phage promoter and in a direction opposite from the direction of transcription of the other phage promoter, each phage promoter sequence being one that is recognized by a phase encoded RNA polymerase which is specific to that phage promoter and which does not recognize the other phage promoter, the two phage promoters being located closely adjacent opposite sides of a cloning site composed of a sequence of DNA base pairs which includes at least one restriction enzyme cleavage site.
Claim 10
Dependent Claim
19 words
The vector of claim 7 wherein the two opposed promoters are the SP6 and T7 late phage promoter sequences.
Claim 11
Dependent Claim
29 words
The vector of claim 7 wherein the cloning site between the two opposed promoter sequences includes at least three restriction sites which are cleaved by three different restriction enzymes.
Claim 12
Dependent Claim
57 words
The vector of claim 7 wherein the cloning site between the two opposed promoters has plural distinct restriction sites selected from the group of sites cleaved by at least one of the following endonucleases; Hind III, Pst I, Sal I, Acc I, Hinc II, Xba I, Bam HI, Ava I, Sma I, Sac I, and Eco RI.
Claim 13
Dependent Claim
19 words
The vector of claim 10 wherein the two opposed promoters are the SP6 and T7 late phage promoter sequences.
Claim 14
Dependent Claim
122 words
A plasmid suited for in vitro production of RNA copies of a cloned DNA sequence comprising: an essentially pure plasmid in circular form having two different phage promoter sequences facing each other such that transcription from either phage promoter proceeds toward the other phage promoter and in a direction opposite from the direction of transcription of the other phage promoter, each phage promoter sequence being one that is recognized by a phase encoded RNA polymerase which is specific to that phage promoter and which does not recognize the other phage promoter, the two phage promoters being located closely adjacent opposite sides of a cloning site composed of a sequence of DNA base pairs which includes at least one restriction enzyme cleavage site.
Claim 15
Dependent Claim
122 words
A plasmid suited for in vitro production of RNA copies of a cloned DNA sequence comprising: an essentially pure plasmid in circular form having two different phage promoter sequences facing each other such that transcription from either phage promoter proceeds toward the other phage promoter and in a direction opposite from the direction of transcription of the other phage promoter, each phage promoter sequence being one that is recognized by a phase encoded RNA polymerase which is specific to that phage promoter and which does not recognize the other phage promoter, the two phage promoters being located closely adjacent opposite sides of a cloning site composed of a sequence of DNA base pairs which includes at least one restriction enzyme cleavage site.
Claim 16
Dependent Claim
19 words
The plasmid of claim 12 wherein the two opposed promoters are the SP6 and T7 late phage promoter sequences.
Claim 17
Dependent Claim
29 words
The plasmid of claim 12 wherein the cloning site between the two opposed promoter sequences includes at least three restriction sites which are cleaved by three different restriction enzymes.
Claim 18
Dependent Claim
58 words
The plasmid of claim 12 wherein the cloning site between the two opposed phage promoters has plural distinct restriction sites selected from the group of sites cleaved by at least one of the following endonucleases: Hind III, Pst I, sal I, Acc I, Hinc II, Xba I, Bam HI, Ava I, Sma I, Sac I, and Eco RI.
Claim 19
Dependent Claim
19 words
The plasmid of claim 15 wherein the two opposed promoters are the SP6 and T7 late phage promoter sequences.
Claim 20
Dependent Claim
24 words
The plasmid of claim 12 including a gene in the plasmid providing ampicillin resistance to competent E. coli bacteria when transformed by the plasmid.
Claim 21
Dependent Claim
12 words
The plasmid of claim 12 wherein the plasmid contains approximately 2.9 kilobases.
Claim 22
Dependent Claim
8 words
The plasmid of claim 12 which is pGEM-1.
Claim 23
Dependent Claim
8 words
The plasmid of claim 12 which is pGEM-2.
References Cited (Backward Citations)
US4237224A
Cited
US4349629A
Cited
US4528266A
Cited
US4403036A
Cited
US4394443A
Cited
US4551433A
Cited
US4495280A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1991-08-23 | 1992-02-22 | 1992-08-23 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1995-08-23 | 1996-02-22 | 1996-08-23 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1999-08-23 | 2000-02-22 | 2000-08-23 | $7700.00 | Window Closed / Lapsed |